Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Blood

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2016-03-704577PMID 27531678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulatory T cells and minimal change nephropathy: in the midst of a complex network

  2016cited by this paper
• Regulatory T cells in immune‐mediated renal disease

  2016cited by this paper
• Reduction in peripheral regulatory T cell population in childhood ocular type myasthenia gravis.

  2015cited by this paper
• Interleukin‐2 critically regulates bone marrow erythropoiesis and prevents anemia development

  2015cited by this paper
• JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells

  2015cited by this paper
• Immune Derangements in Patients with Myelofibrosis: The Role of Treg, Th17, and sIL2Rα

  2015cited by this paper
• Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.

  2015cited by this paper
• Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry

  2015cited by this paper
• Decrease of CD4+ CD25+ CD127low FoxP3+ regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients

  2015cited by this paper
• An Immune Dysregulation in MPN

  2014cited by this paper
• Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?

  2012cited by this paper
• Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.

  2011cited by this paper
• Natural regulatory T cells in autoimmunity

  2011cited by this paper
• Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α.

  2011cited by this paper
• Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.

  2011cited by this paper
• Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.

  2011cited by this paper
• Defects in IL-2R Signaling Contribute to Diminished Maintenance of FOXP3 Expression in CD4+CD25+ Regulatory T-Cells of Type 1 Diabetic Subjects

  2009cited by this paper
• Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.

  2005cited by this paper
• Development and function of CD25+CD4+ regulatory T cells.

  2004cited by this paper
• Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance.

  2004cited by this paper
• Human CD4+ CD25+ regulatory T cells suppress NKT cell functions.

  2003cited by this paper
• CD4+CD25+ TR Cells Suppress Innate Immune Pathology Through Cytokine-dependent Mechanisms

  2003cited by this paper
• The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

  2001cited by this paper
• CD4+CD25+ regulatory T cells down‐regulate co‐stimulatory molecules on antigen‐presenting cells

  2000cited by this paper
• The design and analysis of clinical experiments

  1987cited by this paper

• PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in Ph(-) Myeloproliferative Neoplasm: A Review

  2022cites this paper
• The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: “Crafting” a Microenvironment That Matters

  2021cites this paper
• Expression profile analysis reveals hub genes that are associated with immune system dysregulation in primary myelofibrosis

  2021cites this paper
• Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation.

  2020cites this paper
• The role of circulating monocytes and JAK inhibition in the infectious-driven inflammatory response of myelofibrosis

  2020cites this paper
• Novel targets to cure primary myelofibrosis from studies on Gata1low mice

  2019cites this paper
• CD4+CD25highCD127low/-FoxP3+ Regulatory T-Cell Population in Acute Leukemias: A Review of the Literature

  2019cites this paper
• Role of regulatory T-cells in chronic obstructive pulmonary disease

  2019cites this paper
• GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy

  2018cites this paper
• CD8+ T cells and IFN-γ induce autoimmune myelofibrosis in mice.

  2018cites this paper
• Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies

  2017cites this paper
• Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?

  2017cites this paper
• Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis

  2017cites this paper
• Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease.

  2017cites this paper